Aclarion(us:ACON)

10.80

-10.89%

Updated on 2025-03-31

Open:11.75
Close:10.80
High:11.83
Low:9.75
Prev Close:12.12
Volume:161416.00
Turnover:1.73M
Turnover Ratio:27.73%
Shares:582000.00
MarketCap:6.29M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30123292984.01%543
2024-03-31112725933.81%254
2023-12-3111388400.29%243
2023-09-3015336490.41%228
2023-06-30146157297.51%731
2023-03-3181741162.21%320
2022-12-319318290.40%015
2022-09-3091582712.02%710
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Virtu Financial Llc1151831.61%115183
2024-03-31Captrust Financial Advisors984361.38%68784231.97%
2024-03-31Hrt Financial Lp286390.40%270011648.41%
2024-03-31Citadel Advisors Llc248490.35%231201337.19%
2024-03-31Tower Research Capital Llc (Trc)53720.08%4542547.23%
2024-03-31Bank Of America Corp /De/1000.00%100
2024-03-31Wells Fargo & Company/Mn140.00%11366.67%
2024-03-31State Street Corp0-988
2024-03-31Two Sigma Securities, Llc0-1440
2024-03-31Whittier Trust Co0-603

About

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
Address:8181 Arista Place,Suite 100

Market Movers